(Q45856193)

17 December 2017

title

Parvovirus B19 transmission by heat-treated clotting factor concentrates (English)

1 reference

17 December 2017

author name string

Johannes Blümel

1

1 reference

17 December 2017

Ivo Schmidt

2

1 reference

17 December 2017

Wolfgang Effenberger

3

1 reference

17 December 2017

Holger Seitz

4

1 reference

17 December 2017

Hannelore Willkommen

5

1 reference

17 December 2017

Hans Herrmann Brackmann

6

1 reference

17 December 2017

Johannes Löwer

7

1 reference

17 December 2017

Anna Maria Eis-Hübinger

8

1 reference

17 December 2017

publication date

1 November 2002

1 reference

17 December 2017

published in

Transfusion

1 reference

17 December 2017

volume

42

1 reference

17 December 2017

issue

11

1 reference

17 December 2017

page(s)

1473-1481

1 reference

17 December 2017

Large-scale screening for human parvovirus B19 DNA by PCR: application to the quality control of plasma for fractionation

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00221.X

Albumin batches and B19 parvovirus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00221.X

Infection of the erythroid cell line, KU812Ep6 with human parvovirus B19 and its application to titration of B19 infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00221.X

Eliminating parvovirus B19 from blood products

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00221.X

Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00221.X

Transient hypoplastic anemia caused by primary human parvovirus B19 infection in a previously untreated patient with hemophilia transfused with a plasma-derived, monoclonal antibody-purified factor VIII concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00221.X

Typing of European strains of parvovirus B19 by restriction endonuclease analyses and sequencing: identification of evolutionary lineages and evidence of recombination of markers from different lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00221.X

The VP1-unique region of parvovirus B19: amino acid variability and antigenic stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00221.X

Experimental parvoviral infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00221.X

Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00221.X

Severe aplastic anemia associated with human parvovirus B19 infection in a patient without underlying disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00221.X

Severe parvovirus B19 infection in an immunocompetent child with hemophilia A

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00221.X

High-titer screening PCR: a successful strategy for reducing the parvovirus B19 load in plasma pools for fractionation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00221.X

Parvovirus B19 DNA in plasma pools and plasma derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00221.X

Detection of human parvovirus B19 DNA in plasma pools and blood products derived from these pools: implications for efficiency and consistency of removal of B19 DNA during manufacture

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00221.X

Comparison of the inactivation of canine and bovine parvovirus by freeze-drying and dry-heat treatment in two high purity factor VIII concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00221.X

Transmission of symptomatic parvovirus B19 infection by fibrin sealant used during surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00221.X

Four putative subtypes of human parvovirus B19 based on amino acid polymorphism in the C-terminal region of non-structural protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00221.X

Parvovirus B19: implications for transfusion medicine. Summary of a workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00221.X

Parvovirus B19 infection associated with acute hepatitis and a purpuric exanthem

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00221.X

Human parvovirus B19 infection in acute fulminant liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00221.X

Clinical illness due to parvovirus B19 infection after infusion of solvent/detergent-treated pooled plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00221.X

10.1046/J.1537-2995.2002.00221.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017